+

PE20091462A1 - NUTRITIONAL COMPOSITION BASED ON VITAMINS C AND E, LUTEIN, ZINC, FATTY ACIDS AND COPPER - Google Patents

NUTRITIONAL COMPOSITION BASED ON VITAMINS C AND E, LUTEIN, ZINC, FATTY ACIDS AND COPPER

Info

Publication number
PE20091462A1
PE20091462A1 PE2009000147A PE2009000147A PE20091462A1 PE 20091462 A1 PE20091462 A1 PE 20091462A1 PE 2009000147 A PE2009000147 A PE 2009000147A PE 2009000147 A PE2009000147 A PE 2009000147A PE 20091462 A1 PE20091462 A1 PE 20091462A1
Authority
PE
Peru
Prior art keywords
copper
zinc
lutein
fatty acids
phosphatidyl
Prior art date
Application number
PE2009000147A
Other languages
Spanish (es)
Inventor
Georg Ludwig Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39708779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091462(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20091462A1 publication Critical patent/PE20091462A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

REFERIDA A UNA COMPOSICION QUE COMPRENDE: a) DE 400 MG A 600 MG DE VITAMINA C TAL COMO ASCORBATO DE CALCIO, b) DE 350 UI A 450 UI DE VITAMINA E TAL COMO ACETATO DE D,L-ALFA-TOCOFERILO, c) DE 1 MG A 20 MG DE LUTEINA, d) DE 20 MG A 42 MG DE ZINC TAL COMO OXIDO DE ZINC, e) DE 1000 MG A 1800 MG DE ACIDOS GRASOS OMEGA 3 TALES COMO ACIDO DOCOSAHEXAENOICO (DHA) Y ACIDO EICOSAPENTAENOICO (EPA) Y f) DE 0,8 MG A 1,35 MG DE COBRE TAL COMO CLORURO DE COBRE, CARBONATO DE COBRE, SULFATO DE COBRE, ENTRE OTROS, DONDE EL COBRE SE ENCUENTRA ENMASCARADO O RECUBIERTO POR UN FOSFOLIPIDO ZWITTERIONICO TAL COMO FOSFATIDIL-COLINA, FOSFATIDIL-SERINA, FOSFATIDIL-ETANOLAMINA, ENTRE OTROS. DICHA COMPOSICION SE ENCUENTRA BAJO LA FORMA DE UNA TABLETA, GRAGEA, CAPSULA, AGLOMERADO O SUPOSITORIO Y ES UN SUPLEMENTO NUTRICIONAL O DIETETICO QUE ES UTIL EN LA PREVENCION, ESTABILIZACION Y REVERSION DE LA DEGENERACION MACULAR Y/O PERDIDA DE LA AGUDEZA VISUALREFERRING TO A COMPOSITION THAT INCLUDES: a) FROM 400 MG TO 600 MG OF VITAMIN C SUCH AS CALCIUM ASCORBATE, b) FROM 350 IU TO 450 IU OF VITAMIN E SUCH AS D, L-ALPHA-TOCOPHERYL ACETATE, c) DE 1 MG TO 20 MG OF LUTEIN, d) FROM 20 MG TO 42 MG OF ZINC SUCH AS ZINC OXIDE, e) FROM 1000 MG TO 1800 MG OF OMEGA 3 FATTY ACIDS SUCH AS DOCOSAHEXAENOIC ACID (DHA) AND EICOSAPENTAENOIC ACID (EPA) AND f) FROM 0.8 MG TO 1.35 MG OF COPPER SUCH AS COPPER CHLORIDE, COPPER CARBONATE, COPPER SULPHATE, AMONG OTHERS, WHERE THE COPPER IS MASKED OR COVERED BY A ZWITHTERIONIC PHOSPHOLIPID SUCH AS PHOSPHATIDYL-CHOLINE, PHOSPHATIDYL-SERINE, PHOSPHATIDYL-ETHANOLAMINE, AMONG OTHERS. SAID COMPOSITION IS IN THE FORM OF A TABLET, DRAGEE, CAPSULE, AGGLOMERATE OR SUPPOSITORY AND IS A NUTRITIONAL OR DIETARY SUPPLEMENT THAT IS USEFUL IN THE PREVENTION, STABILIZATION AND REVERSAL OF THE DEGENERATION OF VISUAL VISION AND / OR DEGENERATION

PE2009000147A 2008-02-04 2009-02-02 NUTRITIONAL COMPOSITION BASED ON VITAMINS C AND E, LUTEIN, ZINC, FATTY ACIDS AND COPPER PE20091462A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08151045 2008-02-04

Publications (1)

Publication Number Publication Date
PE20091462A1 true PE20091462A1 (en) 2009-10-23

Family

ID=39708779

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000147A PE20091462A1 (en) 2008-02-04 2009-02-02 NUTRITIONAL COMPOSITION BASED ON VITAMINS C AND E, LUTEIN, ZINC, FATTY ACIDS AND COPPER

Country Status (5)

Country Link
AR (1) AR070405A1 (en)
CL (1) CL2009000230A1 (en)
PE (1) PE20091462A1 (en)
TW (1) TW201000027A (en)
WO (1) WO2009098186A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393710B1 (en) * 2009-04-29 2012-05-08 Graal Srl OROBUCCAL COMPOSITIONS CONTAINING A MIXTURE OF LUTEIN AND ZEAXANTHIN.
RU2589703C2 (en) 2011-09-12 2016-07-10 Тасос ГЕОРГИУ Use of omega fatty acids for treating disease
CN103211216A (en) * 2013-04-25 2013-07-24 福建永生活力生物工程有限公司 Health food with function of improving memory in aided manner and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
WO2005110375A1 (en) * 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
FR2883182B1 (en) * 2005-03-16 2008-02-15 Novartis Ag VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
DE202005012984U1 (en) * 2005-08-17 2005-11-24 W & B Pharmamarken Gmbh Oral combination, useful in the treatment and/or prophylaxis of eye diseases e.g. glaucoma, comprises one or more dosage units comprising e.g. zinc oxide; highly purified fish oil; ascorbic acid and optionally carotenoid, cinnamon
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
CN101330840A (en) * 2005-12-20 2008-12-24 爱尔康研究有限公司 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
DE202006014588U1 (en) * 2006-09-20 2006-12-14 Orthomol Pharmazeutische Vertriebs Gmbh Carotenoid containing product, preferably a balanced diet supplement, useful for age-related eye diseases, comprises vitamins, carotenoids, flavonoids, sulfur containing amino acids, zinc, selenium, chrome, taurine and omega-3-fatty acid

Also Published As

Publication number Publication date
CL2009000230A1 (en) 2009-08-14
TW201000027A (en) 2010-01-01
AR070405A1 (en) 2010-04-07
WO2009098186A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
Zhang et al. Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Teoh et al. The implications of substituting dietary fish oil with vegetable oils on the growth performance, fillet fatty acid profile and modulation of the fatty acid elongase, desaturase and oxidation activities of red hybrid tilapia, Oreochromis sp.
MX2010004820A (en) Lipid mixture for infant nutrition.
PE20200448A1 (en) PRODUCTION OF LONG CHAIN POLYINSATURATED FATTY ACIDS IN VEGETABLE CELLS
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
AU2008296423B2 (en) Preparation of fatty acids in solid form
PH12014501828A1 (en) Methods, compositions, and devices for supplying dietary fatty acid needs
WO2004004599A3 (en) Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
WO2011097276A8 (en) Methods and compositions for treating arthritis with docosahexaenoic acid
JP2011137015A5 (en)
PH12019500030A1 (en) Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
EA201600471A1 (en) EXTRACTED VEGETABLE LIPID, CONTAINING LONG-SECONDENCY POLYNESATURATED FATTY ACIDS
NZ630210A (en) Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
MX2012005744A (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases.
MX2011012955A (en) Nutritional composition for supporting brain development and function of toddlers.
CO6220929A2 (en) COMPLEMENTARY COMPOSITION FOR THE TREATMENT OF EYE DISEASES
PE20091462A1 (en) NUTRITIONAL COMPOSITION BASED ON VITAMINS C AND E, LUTEIN, ZINC, FATTY ACIDS AND COPPER
MX2018001225A (en) Nutritional products having improved lipophilic solubility and bioavailability in an easily mixable form.
RU2009126740A (en) NUTRITION SUPPLEMENT COMPOSITION FOR THE TREATMENT OF EYE DISEASES
RU2009118578A (en) SUPPORTED ENERGY FOOD FOR LONG USE
MY167583A (en) Infant formula with high sn-2 palmitate and oligofructose
JPWO2005061684A1 (en) Oil composition
BRPI0516797A (en) process for the manufacture of food ingredients, process for the manufacture of a human food product, food products and oil mixture
AR087796A1 (en) MICRONUTRIENT SUPPLEMENT
MX2015012543A (en) Method of enhancing bioavailability of dha and other lipid-soluble nutrients.

Legal Events

Date Code Title Description
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载